Correction to: Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer (Oncogene, (2021), 40, 1, (189-202), 10.1038/s41388-020-01515-5)

Che Pei Kung; Kyle A. Cottrell; Sua Ryu; Emily R. Bramel; Raleigh D. Kladney; Emily A. Bao; Eric C. Freeman; Thwisha Sabloak; Leonard Maggi; Jason D. Weber

doi:10.1038/s41388-021-01669-w

Correction to: Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer (Oncogene, (2021), 40, 1, (189-202), 10.1038/s41388-020-01515-5)

Che Pei Kung, Kyle A. Cottrell, Sua Ryu, Emily R. Bramel, Raleigh D. Kladney, Emily A. Bao, Eric C. Freeman, Thwisha Sabloak, Leonard Maggi, Jason D. Weber

Research output: Contribution to journal › Comment/debate

Abstract

The original version of this article unfortunately contained a mistake. The following correction has therefore been made in the original: The word “orthopedic” was changed to “orthotopic” in subheading “Mammary gland orthotopic implantation” and in the first sentence of section “Mammary gland orthotopic implantation”: “The abilities of human breast cancer cell lines to form tumors in vivo were evaluated by performing mammary gland orthotopic implantation as described previously, further details can be found in the Supplementary Information [48].” The original article has been corrected.

Original language	English
Pages (from-to)	2147
Number of pages	1
Journal	Oncogene
Volume	40
Issue number	11
DOIs	https://doi.org/10.1038/s41388-021-01669-w
State	Published - Mar 18 2021

Access to Document

10.1038/s41388-021-01669-w

Cite this

Kung, C. P., Cottrell, K. A., Ryu, S., Bramel, E. R., Kladney, R. D., Bao, E. A., Freeman, E. C., Sabloak, T., Maggi, L., & Weber, J. D. (2021). Correction to: Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer (Oncogene, (2021), 40, 1, (189-202), 10.1038/s41388-020-01515-5). Oncogene, 40(11), 2147. https://doi.org/10.1038/s41388-021-01669-w

@article{10355da171694585be23dba506862469,

title = "Correction to: Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer (Oncogene, (2021), 40, 1, (189-202), 10.1038/s41388-020-01515-5)",

abstract = "The original version of this article unfortunately contained a mistake. The following correction has therefore been made in the original: The word “orthopedic” was changed to “orthotopic” in subheading “Mammary gland orthotopic implantation” and in the first sentence of section “Mammary gland orthotopic implantation”: “The abilities of human breast cancer cell lines to form tumors in vivo were evaluated by performing mammary gland orthotopic implantation as described previously, further details can be found in the Supplementary Information [48].” The original article has been corrected.",

author = "Kung, {Che Pei} and Cottrell, {Kyle A.} and Sua Ryu and Bramel, {Emily R.} and Kladney, {Raleigh D.} and Bao, {Emily A.} and Freeman, {Eric C.} and Thwisha Sabloak and Leonard Maggi and Weber, {Jason D.}",

note = "Publisher Copyright: {\textcopyright} 2021, The Author(s), under exclusive licence to Springer Nature Limited.",

year = "2021",

month = mar,

day = "18",

doi = "10.1038/s41388-021-01669-w",

language = "English",

volume = "40",

pages = "2147",

journal = "Oncogene",

issn = "0950-9232",

number = "11",

}

Kung, CP, Cottrell, KA, Ryu, S, Bramel, ER, Kladney, RD, Bao, EA, Freeman, EC, Sabloak, T, Maggi, L & Weber, JD 2021, 'Correction to: Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer (Oncogene, (2021), 40, 1, (189-202), 10.1038/s41388-020-01515-5)', Oncogene, vol. 40, no. 11, pp. 2147. https://doi.org/10.1038/s41388-021-01669-w

TY - JOUR

T1 - Correction to

T2 - Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer (Oncogene, (2021), 40, 1, (189-202), 10.1038/s41388-020-01515-5)

AU - Kung, Che Pei

AU - Cottrell, Kyle A.

AU - Ryu, Sua

AU - Bramel, Emily R.

AU - Kladney, Raleigh D.

AU - Bao, Emily A.

AU - Freeman, Eric C.

AU - Sabloak, Thwisha

AU - Maggi, Leonard

AU - Weber, Jason D.

PY - 2021/3/18

Y1 - 2021/3/18

N2 - The original version of this article unfortunately contained a mistake. The following correction has therefore been made in the original: The word “orthopedic” was changed to “orthotopic” in subheading “Mammary gland orthotopic implantation” and in the first sentence of section “Mammary gland orthotopic implantation”: “The abilities of human breast cancer cell lines to form tumors in vivo were evaluated by performing mammary gland orthotopic implantation as described previously, further details can be found in the Supplementary Information [48].” The original article has been corrected.

AB - The original version of this article unfortunately contained a mistake. The following correction has therefore been made in the original: The word “orthopedic” was changed to “orthotopic” in subheading “Mammary gland orthotopic implantation” and in the first sentence of section “Mammary gland orthotopic implantation”: “The abilities of human breast cancer cell lines to form tumors in vivo were evaluated by performing mammary gland orthotopic implantation as described previously, further details can be found in the Supplementary Information [48].” The original article has been corrected.

UR - http://www.scopus.com/inward/record.url?scp=85100778277&partnerID=8YFLogxK

U2 - 10.1038/s41388-021-01669-w

DO - 10.1038/s41388-021-01669-w

M3 - Comment/debate

C2 - 33564075

AN - SCOPUS:85100778277

SN - 0950-9232

VL - 40

SP - 2147

JO - Oncogene

JF - Oncogene

IS - 11

ER -

Correction to: Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer (Oncogene, (2021), 40, 1, (189-202), 10.1038/s41388-020-01515-5)

Abstract

Access to Document

Other files and links

Fingerprint

Cite this